glp-1 agonists and sglt2 inhibitors combination Perspectives in weight control in diabetes – GLP-1–glucagon dual agonism GLP-1 & SGLT2 Inhibitor Combination
Description
( B ) Representative Western blot and quantitative densitometric analysis of 83-kDa MTP protein expression in lysates from caSMCs transfected with MTP siRNA, control siRNA, or no siRNA
Upper legs (thighs) the front or outer portion of the thighs
10.1089/thy.2023.0530 22 FemminellaG
References 1.American Diabetes Association Standards of medical care in diabetes2013
[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Stabouli S, et al
